Crescendo Bioscience

About:

Crescendo Bioscience develops diagnostic tools to provide rheumatologists with clinical insights to autoimmune and inflammatory disease.

Website: http://www.crescendobio.com

Twitter/X: myriadgenetics

Top Investors: Myriad Genetics, Safeguard Scientifics, Kleiner Perkins, Mohr Davidow Ventures, TriplePoint Capital

Description:

Crescendo Bioscience, Inc. develops quantitative and objective diagnostic tools to provide rheumatologists with clinical insights to manage patients with autoimmune and inflammatory diseases. It provides diagnostic, prognostic, staging, therapy selection, and monitoring facilities to physicians. Crescendo Bioscience, Inc. was formerly known as Riley Genomics, Inc. The company was founded in 2002 and is based in South San Francisco, California.

Total Funding Amount:

$142M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2002-01-01

Contact Email:

rrogers(AT)myriad.com

Founders:

Michael Centola

Number of Employees:

51-100

Last Funding Date:

2013-01-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai